10-KPeriod: FY2008

Cencora, Inc. Annual Report, Year Ended Sep 30, 2008

Filed November 25, 2008For Securities:COR

Summary

AmerisourceBergen Corporation (now Cencora, Inc.) reported its 2008 fiscal year-end results, highlighting steady revenue growth driven by its Pharmaceutical Distribution segment. The company benefited from an aging population and increased use of pharmaceuticals, including generics. Strategic initiatives included optimizing its distribution network and growing its specialty pharmaceutical business through acquisitions like Bellco Health. The company also divested its workers' compensation business, PMSI, recognizing a significant charge related to this divestiture. Despite facing intense competition and regulatory scrutiny, AmerisourceBergen demonstrated resilience, with management focusing on operational efficiency and strategic growth to navigate the evolving healthcare landscape.

Financial Highlights

53 data points
Beta

Revenue

$70.19B

2.9% Gross Margin

Net Income

$250.56M

0.4% Net Margin

EPS (Diluted)

$0.77

Total Assets

$12.22B

Cash & Equivalents

$878.11M

Free Cash Flow

$599.76M

Financial Statements
Beta
Revenue$70.19B
Cost of Revenue$68.14B
Gross Profit$2.05B
SG&A Expenses$1.12B
Operating Income$827.86M
Net Income$250.56M
EPS (Basic)$0.78
EPS (Diluted)$0.77
Shares Outstanding (Basic)321.28M
Shares Outstanding (Diluted)324.92M

Key Highlights

  • 1Total revenue reached $70.2 billion, a 7% increase year-over-year, primarily driven by the Pharmaceutical Distribution segment.
  • 2Operating income grew 5% to $827.9 million, reflecting improved efficiency in the core distribution business.
  • 3The company completed the acquisition of Bellco Health, bolstering its presence in the New York market and expanding its specialty pharmaceuticals business.
  • 4AmerisourceBergen divested its PMSI workers' compensation business, recognizing a significant non-cash charge of $225.8 million related to the sale.
  • 5The company continued its share repurchase program, buying back $679.7 million of its common stock during fiscal year 2008.
  • 6Significant investments were made in IT infrastructure and business transformation projects, including a new ERP platform, aimed at future cost reductions and operational enhancements.
  • 7The company faced and disclosed various risk factors, including intense competition, potential customer losses, increasing government regulation, and economic uncertainties.

Frequently Asked Questions

The primary revenue driver for AmerisourceBergen in fiscal year 2008 was its Pharmaceutical Distribution segment, which contributed significantly to the company's total revenue of $70.2 billion.

Key strategic actions included acquiring Bellco Health to expand its market presence and specialty business, divesting its PMSI workers' compensation business, and continuing its share repurchase program. The company also focused on internal initiatives like optimizing its distribution network and investing in business transformation projects.

The company identified several key risks, including intense competition from major distributors like Cardinal Health and McKesson, the potential loss of major customers (Medco Health Solutions represented 17% of revenue), increasing government regulation and potential changes in reimbursement policies, and broader economic uncertainties affecting healthcare spending.

The acquisition of Bellco Health for $162.2 million contributed $2.1 billion in revenues in fiscal 2008 and expanded the company's presence in the New York market and its specialty pharmaceuticals business. Acquisitions in fiscal 2007, such as IgG, Access M.D., and Xcenda, also aimed to bolster specialty services and market reach.